Publicacións nas que colabora con Alvaro Ruibal Morell (13)
2024
-
Quantitative brain [18F]FDG PET beyond normal blood glucose levels
NeuroImage, Vol. 300
2021
-
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer? (European Radiology, (2021), 31, 6, (4156-4165), 10.1007/s00330-020-07507-z)
European Radiology
-
Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats
Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360
-
Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
European Radiology, Vol. 31, Núm. 6, pp. 4156-4165
2020
-
-FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage
Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675
-
3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
-
PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337
2019
-
Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model
International Journal of Pharmaceutics, Vol. 572
-
Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models
NeuroImage: Clinical, Vol. 23
-
Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory
Neurobiology of Aging, Vol. 84, pp. 1-8
2018
-
Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model
International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342
-
Preclinical characterization and clinical evaluation of tacrolimus eye drops
European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161
2017
-
In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323